Tag: Evenity

In March 2024, the FDA approved the first interchangeable biosimilars for denosumab, the active ingredient in Prolia. This shift has prompted many to ask: **what drug is replacing Prolia?** The answer involves biosimilars offering similar efficacy and safety at potentially lower costs, alongside unique alternative therapies like Evenity.

Approximately one in two women in the United States will suffer a fracture in their lifetime due to osteoporosis, a chronic and debilitating disease. Many people are searching for a new and convenient treatment, with the query 'What is the new pill for osteoporosis?' being common. However, recent advancements have focused on injectable therapies and biosimilars, while novel oral medications remain in the research and development pipeline.

According to the European Medicines Agency, Evenity is indicated for severe osteoporosis in postmenopausal women with a high risk of fractures. The medication, which is delivered via a prefilled syringe, helps build new bone tissue to strengthen the skeleton and reduce the incidence of future fractures.

Osteoporosis is the most common bone disease in the U.S., significantly increasing the risk of painful fractures due to weakened bones. For many people, injectable medications are a key part of treatment, offering powerful options beyond oral pills. But **what is the injection for bone density loss** that a doctor might prescribe, and how do they differ?.

By 2025, an estimated 500 million people will be living with osteoporosis worldwide [1.7.1]. For those at high risk of fracture, doctors may ask 'What injections do they give for osteoporosis?' to find alternatives to oral medications [1.2.2].